(WEST) Westrock Coffee - Overview
Stock: Coffee, Tea, Extracts, Flavors, Packaging
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 42.1% |
| Relative Tail Risk | -7.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -40.80 |
| Character TTM | |
|---|---|
| Beta | 1.263 |
| Beta Downside | 0.857 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.74% |
| CAGR/Max DD | -0.38 |
Description: WEST Westrock Coffee December 26, 2025
Westrock Coffee Company (NASDAQ: WEST) is an integrated provider of coffee, tea, flavors, extracts, and ingredient solutions serving retail, food-service, convenience, CPG, and hospitality customers in the U.S. and abroad. The firm operates two divisions: Beverage Solutions, which manufactures and packages branded and private-label coffee in formats ranging from bagged beans to ready-to-drink (RTD) cans, and Sustainable Sourcing & Traceability (SS&T), which manages forward contracts and physical delivery of green coffee beans.
Key operating metrics from the most recent 10-K (FY 2023) show revenue of roughly $215 million, with a gross margin of ~38 % and an adjusted EBITDA margin near 12 %. The business is sensitive to commodity price swings-green coffee prices rose ~15 % YoY in 2023-and to consumer trends favoring premium, sustainable, and RTD coffee products, which have been growing at an estimated 7 % CAGR globally. Additionally, Westrock’s supply-chain services benefit from the broader “food-as-a-service” shift, where manufacturers outsource roasting, packaging, and logistics to reduce capital intensity.
For a deeper quantitative dive into WEST’s valuation drivers and scenario analysis, you may find the ValueRay platform’s data visualizations useful.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -92.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA 4.78 > 1.0 |
| NWC/Revenue: 0.85% < 20% (prev 11.31%; Δ -10.46% < -1%) |
| CFO/TA -0.04 > 3% & CFO -52.9m > Net Income -92.5m |
| Net Debt (550.4m) to EBITDA (11.0m): 50.18 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (95.6m) vs 12m ago 7.94% < -2% |
| Gross Margin: 13.90% > 18% (prev 0.18%; Δ 1372 % > 0.5%) |
| Asset Turnover: 95.64% > 50% (prev 77.68%; Δ 17.96% > 0%) |
| Interest Coverage Ratio: -0.80 > 6 (EBITDA TTM 11.0m / Interest Expense TTM 51.7m) |
Altman Z'' -2.23
| A: 0.01 (Total Current Assets 393.6m - Total Current Liabilities 384.5m) / Total Assets 1.18b |
| B: -0.43 (Retained Earnings -510.8m / Total Assets 1.18b) |
| C: -0.04 (EBIT TTM -41.3m / Avg Total Assets 1.13b) |
| D: -0.59 (Book Value of Equity -530.2m / Total Liabilities 893.0m) |
| Altman-Z'' Score: -2.23 = D |
Beneish M -2.86
| DSRI: 0.74 (Receivables 97.7m/102.7m, Revenue 1.08b/836.7m) |
| GMI: 1.29 (GM 13.90% / 18.00%) |
| AQI: 0.91 (AQ_t 0.20 / AQ_t-1 0.22) |
| SGI: 1.29 (Revenue 1.08b / 836.7m) |
| TATA: -0.03 (NI -92.5m - CFO -52.9m) / TA 1.18b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of WEST shares?
Over the past week, the price has changed by +1.42%, over one month by +19.62%, over three months by +19.62% and over the past year by -24.81%.
Is WEST a buy, sell or hold?
- StrongBuy: 5
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WEST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.5 | 90% |
| Analysts Target Price | 9.5 | 90% |
| ValueRay Target Price | 4.7 | -6.4% |
WEST Fundamental Data Overview February 03, 2026
P/B = 40.9572
Revenue TTM = 1.08b USD
EBIT TTM = -41.3m USD
EBITDA TTM = 11.0m USD
Long Term Debt = 433.3m USD (from longTermDebt, last quarter)
Short Term Debt = 106.7m USD (from shortTermDebt, last quarter)
Debt = 598.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 550.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.02b USD (467.7m + Debt 598.7m - CCE 48.4m)
Interest Coverage Ratio = -0.80 (Ebit TTM -41.3m / Interest Expense TTM 51.7m)
EV/FCF = -6.74x (Enterprise Value 1.02b / FCF TTM -151.1m)
FCF Yield = -14.84% (FCF TTM -151.1m / Enterprise Value 1.02b)
FCF Margin = -14.01% (FCF TTM -151.1m / Revenue TTM 1.08b)
Net Margin = -8.58% (Net Income TTM -92.5m / Revenue TTM 1.08b)
Gross Margin = 13.90% ((Revenue TTM 1.08b - Cost of Revenue TTM 928.6m) / Revenue TTM)
Gross Margin QoQ = 11.67% (prev 14.74%)
Tobins Q-Ratio = 0.86 (Enterprise Value 1.02b / Total Assets 1.18b)
Interest Expense / Debt = 2.34% (Interest Expense 14.0m / Debt 598.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -32.6m (EBIT -41.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.02 (Total Current Assets 393.6m / Total Current Liabilities 384.5m)
Debt / Equity = 2.10 (Debt 598.7m / totalStockholderEquity, last quarter 285.0m)
Debt / EBITDA = 50.18 (Net Debt 550.4m / EBITDA 11.0m)
Debt / FCF = -3.64 (negative FCF - burning cash) (Net Debt 550.4m / FCF TTM -151.1m)
Total Stockholder Equity = 323.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.20% (Net Income -92.5m / Total Assets 1.18b)
RoE = -28.60% (Net Income TTM -92.5m / Total Stockholder Equity 323.4m)
RoCE = -5.45% (EBIT -41.3m / Capital Employed (Equity 323.4m + L.T.Debt 433.3m))
RoIC = -5.99% (negative operating profit) (NOPAT -32.6m / Invested Capital 544.3m)
WACC = 5.67% (E(467.7m)/V(1.07b) * Re(10.57%) + D(598.7m)/V(1.07b) * Rd(2.34%) * (1-Tc(0.21)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.18%
Fair Price DCF = unknown (Cash Flow -151.1m)
EPS Correlation: 7.81 | EPS CAGR: -0.57% | SUE: 0.60 | # QB: 0
Revenue Correlation: 60.80 | Revenue CAGR: 18.06% | SUE: 3.81 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.013 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.12 | Chg30d=+0.021 | Revisions Net=-2 | Growth EPS=+84.4% | Growth Revenue=+14.9%